Lux Capital

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lux Capital
Type Private
Industry Venture capital
Founded 2000
Founder(s) Peter Hébert
Robert Paull
Josh Wolfe
Headquarters New York, NY, USA
Website luxcapital.com

Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm invests in emerging technologies in the physical and life sciences.[3][4]

The firm is based in New York, with partners also located in Palo Alto and San Diego. The Lux Capital team has built more than 20 companies from scratch.[3]

Lux's principals have been interested in developing improved methods for the treatment or remediation of nuclear waste, to assist the nuclear power industry.[3]

Lux Capital's portfolio companies include Accelergy,[5] Cambrios, Cerulean Pharma,[4] Crystal IS, Everspin,[2] Genocea Biosciences,[2][4] GridCo, Kala Pharmaceuticals,[4] Kereos, Kurion, Kymeta, Lux Research, Luxtera,[3] Magen Biosciences, Molecular Imprints, Nanosys, Visterra,[6] QD Soleil, SiBEAM, Shapeways, Silicon Clocks, Siluria Technologies, and Transphorm.[7]

In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners.[8]

In August 2012, form Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.[9]

With offices in New York and Palo Alto, California, Lux manages about $350 million in assets.[10]

See also[edit]

References[edit]

  1. ^ Fickenscher, Lisa (2003). "2003 40 Under 40". Crain's New York Business. Jan 27 - Feb 2, 2003: 15–31. ISSN 8756-789X. OCLC 11620213. 
  2. ^ a b c Eden, Scott (2009). "Nano Wunderkinds". Dealmaker. December/January 2009: 35–37. ISSN 1937-304X. OCLC 132936538. 
  3. ^ a b c d Bigelow, Bruce V. (6 May 2009). "Lux Capital’s Larry Bock and Josh Wolfe Warm to Venture Deals Despite Nuclear Winter". Xconomy. Retrieved 17 January 2010. 
  4. ^ a b c d Timmerman, Luke (23 Dec 2009). "Kala Pharmaceuticals, Stealthy New Company Tied to MIT’s Bob Langer, Gets $2M". Xconomy. Retrieved 18 January 2010. 
  5. ^ Bullis, Kevin (25 Jan 2010). "Cleaner Jet Fuel from Coal". Technology Review. Retrieved 1 February 2010. 
  6. ^ Lang, Michelle (12 Jul 2010). "Visterra takes in $6M VC funds, launches Singapore arm". Xconomy. Retrieved 1 June 2011. 
  7. ^ Roushe, Wade (23 Feb 2011). "Google Ventures Leads $20M Round for Transphorm to Battle Hidden Tax in Power Conversion". Xconomy. Retrieved 25 February 2010. 
  8. ^ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011. 
  9. ^ "Kindler, Former Pfizer Chief, Joins Lux Capital". Dealbook. 8 August 2012. 
  10. ^ "Lux Capital Raises $245 Million to Fund Unpopular Science Startups". Bloomberg. 13 February 2013. 

External links[edit]